
STROMUSC Stanozolol(Winstrol)100mg/ml Water For Bodybuilding CAS:10418-03-8
Stanozolol, universally recognized by its original brand name Winstrol, occupies a unique and often misunderstood niche within the bodybuilding pharmacopeia. Its presentation as a 100mg/ml water-based suspension represents a specific, potent, and particularly challenging formulation favored by some athletes seeking extreme leanness and vascularity. This analysis delves beyond surface-level descriptions to provide a novel examination of this high-concentration preparation, its mechanisms, perceived benefits, inherent dangers, and the harsh realities of its use.
What It Is: Beyond the Generic Label
Stanozolol is a synthetic anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). Its core molecular structure features a pyrazol group fused to the A-ring and a 17α-methyl group. This 17α-alkylation is crucial: it allows oral bioavailability but imposes significant hepatic stress. While commonly associated with oral tablets, Stanozolol is also formulated for injection. The "Winstrol 100mg/ml Water" variant specifically refers to an aqueous suspension, not a solution.
●The Suspension Distinction: Unlike oil-based steroid solutions where the hormone is dissolved, aqueous suspensions contain micronized Stanozolol crystals suspended in sterile water. This creates a milky white liquid requiring vigorous shaking before each injection. The 100mg/ml concentration is notably supraphysiological and far exceeds therapeutic doses (typically 2-6mg daily for medical conditions like hereditary angioedema). This extreme concentration is purely a bodybuilding artifact, driven by the desire to minimize injection volume for high doses.


Features: The Double-Edged Sword of High-Concentration Suspension
●High Potency, Low Volume: The primary perceived feature is delivering 100mg of active compound per milliliter, allowing large doses with relatively small injection volumes (e.g., 1ml for 100mg). This is attractive for site injections or minimizing total fluid load.
●Water-Based Carrier: Eliminates the need for oil solvents, potentially reducing certain types of injection site reactions (like persistent lumps from slow-absorbing oils). However, it introduces other issues:
○Rapid Absorption & Short Half-Life (Relative): Water suspensions are absorbed faster than oil-based solutions from the injection site. However, the Stanozolol molecule itself still dictates the systemic half-life. This creates a pharmacokinetic mismatch – rapid depot clearance but sustained systemic presence.
○Pain and Irritation Paradox: The high concentration of crystalline material suspended in water is inherently irritating to tissues. Injections are notoriously painful, frequently causing significant localized inflammation, swelling (sterile abscesses), and redness. The pain often exceeds that of many oil-based injectables.
○Instability & Clogging Risk: Suspensions are prone to settling and clumping. Inadequate shaking leads to inconsistent dosing (mostly water initially, concentrated crystals later). Fine crystals can clog needles, especially smaller gauges required for less painful administration, creating a vicious cycle.
●C17-α-Alkylated: This modification grants oral bioavailability but renders the compound hepatotoxic. Liver stress is a primary concern, especially at bodybuilding doses and durations. The injectable form bypasses first-pass metabolism to some degree, but the alkylation ensures significant liver impact regardless of administration route.
●Non-Aromatizing: Stanozolol does not convert to estrogen (aromatize). This eliminates risks like gynecomastia and significant water retention common with testosterone or Dianabol.
●Low Progestogenic Activity: Negligible interaction with progesterone receptors, avoiding related side effects like prolactin elevation.
●DHT Derivative: Inherits strong binding affinity to androgen receptors in skin, scalp, and prostate. Side effects like accelerated male pattern baldness, acne (especially back/shoulders), and potential prostate irritation are common.
Applications in Bodybuilding: The Pursuit of the "Dry Look"
Stanozolol's primary application is during the pre-contest phase or during specific cutting cycles where the goal is extreme fat loss, muscle hardening, and enhanced vascularity without subcutaneous water retention.
●Muscle Preservation in Caloric Deficit: Its anabolic activity, though moderate compared to bulking steroids, helps protect lean muscle mass when athletes are in severe calorie restriction necessary for stage leanness. This is arguably its most legitimate performance application.
●Enhanced Vascularity & Muscle "Hardness": The combination of fat loss, diuretic effect (via inhibition of the antidiuretic hormone vasopressin), and lack of water retention creates the prized "dry," "grainy," and highly vascular appearance. This is purely aesthetic but paramount in competitive bodybuilding.
●Strength Gains Without Bulk: Some athletes use it off-season for strength gains without significant water weight or excessive size increase, though this is less common than contest prep use. The strength gains are often attributed more to neurological efficiency and collagen synthesis impacts than massive hypertrophy.
●Synergy in Stacks: Frequently stacked with other non-aromatizing or low-aromatizing compounds like Masteron, Primobolan, Trenbolone, or low-dose Testosterone Propionate to amplify the hardening/drying effect. Oral Winstrol is sometimes added on top for a "peak week" effect, exacerbating liver strain.
Perceived Benefits vs. Harsh Realities:
●Perceived:
○Dramatic fat loss (primarily driven by extreme diet/cardio, but Stanozolol may slightly enhance lipolysis).
○Unparalleled muscle hardness and density.
○Significant increase in vascularity.
○Strength maintenance or increase during cutting.
○No estrogenic side effects (gynecomastia, water bloat).
●Harsh Realities & Side Effects:
○Severe Hepatotoxicity: Liver enzyme elevation (AST/ALT) is virtually guaranteed. Risk of cholestasis, jaundice, hepatic peliosis, and long-term damage is significant, especially at 100mg/ml doses and cycles exceeding 6-8 weeks. Combining with other oral AAS or alcohol is exceptionally dangerous.
○Excruciating Injections: The 100mg/ml suspension is infamous for causing intense, sometimes debilitating, localized pain, inflammation, and potential sterile abscesses. Rotating sites is difficult due to the pain.
○Catastrophic Lipid Profile: Crushes HDL ("good" cholesterol) and often elevates LDL ("bad" cholesterol), significantly increasing cardiovascular disease risk long before visible symptoms appear. This effect is profound and persistent.
○Joint Pain & "Pseudovulnerability": Stanozolol reduces collagen synthesis and synovial fluid viscosity. Combined with extreme leanness (loss of protective fat padding) and often concurrent diuretic use, this leads to debilitating joint pain (knees, elbows, shoulders) and a markedly increased risk of tendon tears and ligament injuries under heavy load. This "pseudovulnerability" – muscles strong but connective tissues weakened – is a hallmark danger.
○Virilization (in Women): High risk of irreversible masculinizing effects: voice deepening, clitoromegaly, facial/body hair growth, disrupted menstrual cycle.
○Androgenic Side Effects: Acne (often severe/cystic), accelerated male pattern baldness, increased body/facial hair, aggression ("roid rage" is less common than with some AAS, but irritability is frequent), potential prostate enlargement.
○Suppression of Natural Testosterone: Severe HPTA shutdown requiring Post Cycle Therapy (PCT).
○Potential Cardiovascular Strain: Can increase blood pressure and contribute to left ventricular hypertrophy, compounded by poor lipid profiles.
Dosage & Administration: Navigating High-Stakes Terrain
Dosage is highly individual and controversial. The 100mg/ml concentration inherently encourages higher dosing due to volume convenience, significantly amplifying risks.
●Male Dosage Range:
○Injectable (100mg/ml): 25mg to 100mg every other day (EOD) is common, equating to 0.25ml to 1ml per injection. *50mg EOD (0.5ml) is often cited as a "safer" high-end, but safety is relative and liver/HDL impact is still severe.* Doses above 50mg EOD exponentially increase side effects.
○Oral: 40mg to 100mg per day (often split doses). Combining injectable and oral is extremely hepatotoxic.
●Female Dosage Range: Use is strongly discouraged due to virilization risks. If used, doses are extremely low (e.g., 5mg oral every other day or 5-10mg injectable E3D or less), but risks remain very high. The 100mg/ml concentration makes precise low dosing difficult.
●Administration: MUST be shaken vigorously until uniform immediately before drawing. Intramuscular (IM) injection only. Due to pain and tissue irritation, deep gluteal or vastus lateralis (quad) sites are common, but rotation is key (though painful). Use appropriate needle gauge (e.g., 23-25G). Aspirate to avoid intravenous injection (crystals can cause pulmonary issues if injected IV). Expect significant post-injection pain (PIP).
Cycle Architecture: Short, Sharp, and Dangerous
Cycles are typically short due to liver toxicity and joint issues.
●Duration: 6-8 weeks is common, rarely exceeding 10 weeks. Longer cycles dramatically increase the risk of irreversible damage.
●Solo Use: Rare. Limited benefit for muscle gain.
●Cutting Stack Examples:
○"Classic Hardener": Testosterone Propionate (50-100mg EOD) + Stanozolol (50mg EOD) + Masteron (100mg EOD) - Weeks 1-8. High androgenic load, significant liver/heart strain.
○"Contest Peak": Trenbolone Acetate (50-75mg EOD) + Stanozolol (50mg EOD) - Weeks 6-12 out from a show. Extremely harsh on lipids, mood, and cardiovascular health.
○Oral Bridge/Peak: Injectable base (e.g., Test P/Mast) + Oral Stanozolol (50-80mg/day) for the final 4-6 weeks. Direct hepatic assault.
●Crucial Consideration: Adding Stanozolol, especially at 100mg/ml doses, to any cycle drastically increases hepatotoxicity and cardiovascular strain. It transforms a cycle into a high-risk endeavor.
Half-Life: The Misconception of "Short"
●Stanozolol Half-Life: Approximately 9 hours for the oral form. The injectable suspension has a notably longer half-life due to the depot effect created by the crystals at the injection site.
●Injectable Suspension PK: While absorption from the water depot is faster than from oil, the systemic elimination half-life of Stanozolol remains relatively consistent. The injectable form provides a more sustained release compared to oral dosing, leading to more stable blood levels over 24-48 hours. This is why injectable dosing is typically Every Other Day (EOD), not daily like the oral form. The 100mg/ml concentration maintains significant blood levels on this schedule. Myth Buster: The water base does NOT make it a "short ester" requiring daily injections. EOD is standard.
Post Cycle Therapy (PCT): Essential Damage Control
HPTA suppression is profound. PCT is non-negotiable but challenging due to Stanozolol's impact on lipids and potential lingering liver strain.
●Timing: Start PCT approximately 24-48 hours after the last Stanozolol injection due to its half-life.
●Goals: Restore endogenous testosterone production, mitigate estrogen rebound (even though Winny doesn't aromatize, the body may rebound as exogenous androgens clear), manage cortisol, and begin lipid/liver recovery.
●Typical PCT Protocol (Example - Adjust based on pre-cycle bloods and cycle intensity):
○Week 1-4: Selective Estrogen Receptor Modulator (SERM) - Tamoxifen Citrate (20mg daily) OR Clomiphene Citrate (50mg daily).
○Week 1-6 (Optional but Recommended): Aromatase Inhibitor (AI) - Low dose (e.g., Anastrozole 0.25mg EOD) only if bloodwork or symptoms indicate high estrogen. Use cautiously.
○Liver Support (Crucial): Continue high-dose NAC (1200-1800mg/day), TUDCA (500-1000mg/day), and Milk Thistle throughout PCT and beyond.
○Cardio/Lipid Support: Aggressive dietary intervention (high fiber, omega-3s, plant sterols), increased cardio, potentially supplements like Citrus Bergamot, Niacin (flushing type, monitored), CoQ10. Statin drugs may be necessary later but require medical supervision.
○Bloodwork: Essential pre-PCT (to confirm suppression) and post-PCT (6-8 weeks after finishing SERM/AI) to assess recovery of Testosterone, LH, FSH, lipids, and liver enzymes.
Clinical Data
| Brand | STROMUSC |
| Trade names |
Stanozolol, Stromba, Androstanazol; Androstanazole; Stanazol |
|
CAS |
10418-03-8 |
|
Molar mass |
328.500 |
|
Formula |
C21H32N2O |
|
Purity |
Above 98% |
|
Capacity |
100mg/ml,10ml/bottle |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885

Conclusion: The Epitome of Risk-Reward Calculation
Stanozolol 100mg/ml water suspension represents a high-octane, high-risk tool exclusively for the final stages of competitive bodybuilding. Its extreme concentration offers dosing convenience but magnifies its inherent dangers: severe hepatotoxicity, catastrophic lipid disruption, debilitating joint issues, and intensely painful injections. The pursuit of the "dry look" comes at a formidable physiological cost. The benefits – muscle preservation during extreme dieting, enhanced vascularity, and hardness – are potent but temporary and largely aesthetic. The side effects, however, can be permanent and life-altering. Its use demands an acute awareness of these risks, meticulous harm reduction strategies (including comprehensive bloodwork), and an understanding that this compound pushes the boundaries of physiological tolerance far beyond therapeutic or sustainable limits. For the vast majority of athletes, the perils associated with this specific formulation far outweigh any potential reward.
Hot Tags: STROMUSC Stanozolol(Winstrol)100mg/ml Water For Bodybuilding CAS:10418-03-8, China STROMUSC Stanozolol(Winstrol)100mg/ml Water For Bodybuilding CAS:10418-03-8 manufacturers, suppliers, factory
